Licht T - Search Results

1

Fruehauf S, Veldwijk MR, Berlinghoff S, Basara N, Baum C, Flasshove M, Hegewisch-Becker S, Kröger N, Licht T, Moritz T, Hengge UR, Zeller WJ, Laufs S. Fruehauf S, et al. Among authors: licht t. Cells Tissues Organs. 2002;172(2):133-44. doi: 10.1159/000065614. Cells Tissues Organs. 2002. PMID: 12426490 Review.

2

The multidrug-resistance gene in gene therapy of cancer and hematopoietic disorders.

Licht T, Pastan I, Gottesman MM, Herrmann F. Licht T, et al. Ann Hematol. 1996 Apr;72(4):184-93. doi: 10.1007/s002770050159. Ann Hematol. 1996. PMID: 8624371 Review.

3

In vivo drug-selectable genes: a new concept in gene therapy.

Licht T, Herrmann F, Gottesman MM, Pastan I. Licht T, et al. Stem Cells. 1997;15(2):104-11. doi: 10.1002/stem.150104. Stem Cells. 1997. PMID: 9090786 Review.

4

Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.

Schlemmer M, Wendtner CM, Falk M, Abdel-Rahman S, Licht T, Baumert J, Straka C, Hentrich M, Salat C, Hiddemann W, Issels RD. Schlemmer M, et al. Among authors: licht t. Oncology. 2006;71(1-2):32-9. doi: 10.1159/000100447. Epub 2007 Mar 5. Oncology. 2006. PMID: 17344669 Clinical Trial.

5

Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro.

Licht T, Fiebig HH, Bross KJ, Herrmann F, Berger DP, Shoemaker R, Mertelsmann R. Licht T, et al. Int J Cancer. 1991 Oct 21;49(4):630-7. doi: 10.1002/ijc.2910490427. Int J Cancer. 1991. PMID: 1917165

6

Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: analysis of remission induction and stem cell mobilization.

Menzel H, Müller A, Von Schilling C, Licht T, Peschel C, Keller U. Menzel H, et al. Among authors: licht t. Leuk Lymphoma. 2008 Jul;49(7):1337-44. doi: 10.1080/10428190802094229. Leuk Lymphoma. 2008. PMID: 18604723 Clinical Trial.

7

Transfer of the MDR1 (multidrug resistance) gene: protection of hematopoietic cells from cytotoxic chemotherapy, and selection of transduced cells in vivo.

Licht T, Gottesman MM, Pastan I. Licht T, et al. Cytokines Mol Ther. 1995 Mar;1(1):11-20. Cytokines Mol Ther. 1995. PMID: 9384659 Review.

8

Efficient expression of functional human MDR1 gene in murine bone marrow after retroviral transduction of purified hematopoietic stem cells.

Licht T, Aksentijevich I, Gottesman MM, Pastan I. Licht T, et al. Blood. 1995 Jul 1;86(1):111-21. Blood. 1995. PMID: 7795216 Free article.

9

[Current issues in somatic gene therapy].

Licht T, Hafkemeyer P. Licht T, et al. Dtsch Med Wochenschr. 1999 Jun 4;124(22):700-6. doi: 10.1055/s-2007-1024401. Dtsch Med Wochenschr. 1999. PMID: 10394351 Review. German. No abstract available.

10

Retroviral transfer of human MDR1 gene to hematopoietic cells: effects of drug selection and of transcript splicing on expression of encoded P-glycoprotein.

Licht T, Aran JM, Goldenberg SK, Vieira WD, Gottesman MM, Pastan I. Licht T, et al. Hum Gene Ther. 1999 Sep 1;10(13):2173-85. doi: 10.1089/10430349950017167. Hum Gene Ther. 1999. PMID: 10498249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters